CB Pharma Acquisition
Burlington, US · Founded 2014
Healthtech
Founders & leadership
AJ
Adam J. ChillNamed on SEC filing
NH
Neil HerskowitzNamed on SEC filing
GC
George C. AvgerinosNamed on SEC filing
MS
Michael S. WeissNamed on SEC filing
AA
Arthur A. KornbluthNamed on SEC filing
LA
Lindsay A. RosenwaldNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.9M disclosed across 1 round · 2014
▶$2.9MraisedDec 2014 · 2 investors · Other Health CareRule 506(b)
▶$2.9MraisedDec 2014 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Adam J. ChillDirector
- Neil HerskowitzDirector
- George C. AvgerinosExecutive Officer
- Michael S. WeissDirector
- Arthur A. KornbluthDirector
- Coronado Biosciences, Inc.Promoter
- Lindsay A. RosenwaldExecutive Officer, Director, Promoter
- Offering amount
- $2.9M
- Amount sold
- $2.9M
- First sale
- Nov 2014
- Incorporated
- Corporation, Cayman Islands, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has CB Pharma Acquisition raised?
- CB Pharma Acquisition has disclosed $2.9M raised across 1 round.
- Where is CB Pharma Acquisition headquartered?
- CB Pharma Acquisition is headquartered in Burlington, US.